
WISeKey International Holding Ltd posts US$36.4M H1 loss as revenue doubles
Gross margin reached about 48 per cent in the June half, while WISeQey shares are due to trade as WQEY on Oct. 5 after an ADS conversion.

Northcliff says the Sept. 23-effective report makes no material change to August's results; it holds 88.5 per cent of the partnership that owns Sisson.

Gross margin reached about 48 per cent in the June half, while WISeQey shares are due to trade as WQEY on Oct. 5 after an ADS conversion.

The ARTG's Sept. 15 entry names Jupiter Research as manufacturer; Curaleaf also reports a Sept. 17 New Zealand WAND notification.
The AUTUS pulmonary valve can later be widened by catheter; the FDA cited a 62-child study and flagged longer-term risks.
Facility A begins at 7.25 per cent and Facility B stays at 9.95 per cent under a Sept. 28 agreement backed by subsidiary assets.

A 1.21-metre section graded 30.46% antimony, while the 2025 feasibility study assigns the metal no revenue.

Shareholders approved the Armada combination Sept. 30, while Evernorth expects roughly US$300M of gross cash before expenses.

Japan approved use with gemcitabine and nab-paclitaxel; Novocure's Oct. 1 release gave no Japanese shipment or coverage date.

The Erwin, Tennessee, unit will make reactor fuel for the naval propulsion program, with work scheduled for completion in August 2027.
Colorado completed its review on Sept. 29; permit issuance requires verified warranties, and DOE mine-plan approval remains pending.
Lifted Made closed the Kenosha building sale Sept. 29 and used US$841,110 to repay all its outstanding bank debt.
The FCA approved a prospectus on Sept. 29; MORE starts with a £12 annual dividend per share and has an Oct. 9 retail deadline.
Commerce's Bureau of Industry and Security authorised sales under specified terms; the company did not name an export buyer or shipment date.
Jabil expects US$17.55 core EPS and a 6.1 per cent core operating margin in fiscal 2027 after quarterly revenue rose year on year.
Yancoal will recognize its share of Kestrel's production, revenue and earnings from Oct. 1 and expects to dispatch a circular to shareholders by Nov. 23.
The Australian explorer is selling 625,000 depositary shares with matching warrants and expects the financing to close Oct. 2.
Gold, silver, uranium, lithium, copper and rare earths: the producers, the developers and the projects behind them.
View all
Marimaca's Oct. 1 update names no supplier, contracted volume or energization date for its preliminary five-year power framework.
Medical and pharmaceutical developments, psychedelics, and the research and safety questions around them.
View all
A small post hoc MRI subgroup improved after 72 weeks, while placebo comparisons came from other liver measures in the larger STEP UP dataset.
Technology, computing, crypto and cannabis, and the listed companies moving in them.
View all
The uncontrolled Canadian trial enrolled 11 patients; seven were evaluable for pain, and validated data analysis remains underway.
Enerflex schedules deliveries to an unnamed North American developer from 2027 through 2028 and has authorized US$85M for systems facilities.
Uranium, lithium, oil and gas, hydrogen and the grid: the fuels and the companies behind them.
View all
South Korea's nonbinding financing framework could support up to eight U.S. reactors; Cameco says final agreements and sites remain pending.

The first hole's 1.1-metre section graded 1.10 per cent, while assays from 18 more drilled holes remain outstanding.

Amentum says Sellafield's PACE framework would run for nine years, with an option to extend it by six years.
Licensed producers, retail, policy, and the psychedelics companies moving through the clinic.
View all
A Sept. 29 stay in DEA hearing docket 26-96 sets Oct. 13 for a response to a motion seeking to add the GAO report to the record.

Holders have until Oct. 23 to vote on one new share for five to 15 existing shares, nomination rules and incentive-plan entitlements.

Battle Green can require a share-funded note purchase, while Vireo can trigger one at a lower share price; the maturity route uses a future trading average.

IMC Holdings retains liabilities under a C$9.4M cap subject to mutual adjustment; direct subsidiary debts are excluded from that cap.